Publication
A phase II randomized study of proton therapy vs intensity-modulated radiation therapy in patients with unilateral head and neck cancer.
Edward Christopher Dee, Noah S Kalman, Daniel J Ma, Scott C Lester, Zhigang Zhang, Daphna Gelblum, Yao Yu, Linda Chen, Sean M McBride, Nadeem Riaz, Boris A Mueller, Achraf Shamseddine, Kaveh Zakeri, Jung Julie Kang, Chiaojung Jillian Tsai, Yingzhi Wu, Dennis Mah, Kevin Sine, Andy Shim, Haibo Lin, Alan Ho, Richard J Wong, Paul B Romesser, Christopher A Barker, Nancy Y Lee
- Source
- PubMed
- Retrieved
- Sep 30, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260930-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
Proton beam radiotherapy (PBRT) offers dosimetric advantages over intensity-modulated radiation therapy (IMRT), but prospective randomized data in the postoperative unilateral head and neck cancer setting remain limited. We conducted a multicenter, randomized phase II trial comparing PBRT and IMRT…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Validated 1
- trialNCT02923570registry_reference1.00
Registered trialsNCT02923570
Curated evidence
Evidence citing this paper (0)
Data not yet available